司帕生坦的购买渠道

Introduction: Sparsentan is used to treat adult patients with primary immunoglobulin A nephropathy (IgAN) who are at risk of rapid disease progression. Its purchasing channels and price information are crucial to patients. This article will provide practical reference information for patients who need to obtain this drug from three aspects: legal purchase channels, global listing status, and price comparison of different versions.

Purchase channels for sparsentan

Due to the special nature of the drug, patients need to obtain it through formal channels to ensure the quality of the drug.

Cross-border medical service institutions

Professional cross-border medical service institutions can help patients connect with regular overseas medical institutions and provide drug purchase services. After purchasing the drugs, they can obtain the drugs through direct mail.

Direct mail from international pharmacies

Some nationally authorized pharmacies support prescription review services and can be delivered by international express delivery. Before purchasing medicines, you need to confirm that the pharmacy has legal business qualifications.

Overseas medical treatment and drug purchase

Patients can choose to go to the United States for medical treatment to obtain a prescription and purchase it locally in an approved country, or they can obtain a medication plan through international consultation.

In all purchasing processes, complete receipts and drug packaging should be retained to facilitate subsequent traceability and rights protection.

The marketing status of sparsentan

Understanding the global marketing status of drugs can help patients plan their access.

US market situation

It received accelerated approval from the FDA in 2023. The indication is IgA nephropathy. The manufacturer is Travere Therapeutics and the trade name is Filspari.

Approval in other regions

The current major approval regions include the United States (fully approved), the European Union (conditional listing), and Japan (under review).

Domestic registration progress

The State Food and Drug Administration of China has not yet received the marketing application, it has not been included in the priority review, and there is no clear time for launch.

Patients need to pay attention to the approval status of official channels to obtain the latest marketing information.

Sparsentan Price

Drug prices vary significantly depending on the source and version. Understanding pricing can help you plan your treatment budget appropriately.

Original drug pricing

The specifications produced by Travere Therapeutics are 400mg*30 tablets/box, and the price is approximately US$15,277.

Generic drug selection

The reference price of the Laos Lucius version with the same specifications is approximately US$1,073 per box, which has an obvious price advantage.

Cost influencing factors

The main reasons for price differences include patent protection status, production process standards, regional pricing policies, transportation and warehousing costs, etc.

Patients can choose a suitable version according to their economic status, while taking into account the cost pressure of subsequent continued treatment.